Loncastuximab tesirine (ADC)

• Description:

  Loncastuximab tesirine is an ADC consisting of a CD19-directed antibody and Tesirine that induces cell apoptosis and is used for the study of diffuse B cell lymphoma and non-Hodgkin's lymphoma.

• Product Name Alternative:

  ZYNLONTA

• Reactivity:

  Human

• Applications:

  Research Grade Biosimilar

• Stability:

  Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks) . Store at -20°C 12 months. Store at -80°C long term.

• Endotoxin:

  Please contact with the lab for this information.

• Purity:

  >90% as determined by SEC.

• Form:

  Liquid

• Notes:

  For research use only. Not suitable for clinical or therapeutic use.